Publications by authors named "Jorge Monge"

Claim this Profile
R
Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis.
Gaurav Varma, Lindsay Fogel, Beth Gordon, Mateo Mejia Saldarriaga, Jaeil Ahn, Jorge Monge

Leuk Lymphoma· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring health disparities in diagnosing multiple myeloma.
Nima Ghalehsari, Sofia Zahid, Olivia Main, Soeb Usta, John Patresan, Jorge Monge

Expert Rev Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma.
Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, Tarek H Mouhieddine, Juan Esteban Velez-Hernandez, Jorge Monge

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current landscape of CD3 bispecific antibodies in hematologic malignancies.
Joshua Kassner, Basma Abdellatif, Samuel Yamshon, Jorge Monge, Justin Kaner

Trends Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study.
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin

Blood Cancer J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg

Blood Cancer J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy.
Jorge Monge, Meri Razavi, Liming Bao, Sanjay S Patel

Am J Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment.
Muhamed Baljevic, Cristina Gasparetto, Gary J Schiller, Sascha A Tuchman, Natalie S Callander, Jorge Monge

EJHaem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemia.
Terrence Bradley, Deukwoo Kwon, Jorge Monge, Mikkael Sekeres, Namrata Chandhok

EJHaem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance.
Mateo Mejia Saldarriaga, Walaa Darwiche, David Jayabalan, Jorge Monge, Cara Rosenbaum

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The unpredictable carbon nanotube biocorona and a functionalization method to prevent protein biofouling.
Lorena García-Hevia, Mahsa Saramiforoshani, Jorge Monge, Nerea Iturrioz-Rodríguez, Esperanza Padín-González

J Nanobiotechnology· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice.
Donatella Londero, Jorge Monge, Asa Hellberg

Vox Sang· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous multiple myeloma and Gaucher disease.
Jorge Monge, Amy Chadburn, Usama Gergis

Hematol Oncol Stem Cell Ther· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure Patients: A Systematic Review and Meta-Analysis.
Gabriel A Hernandez, Vanessa Blumer, Luis Arcay, Jorge Monge, Juan F Viles-Gonzalez

JACC Heart Fail· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collection, storage, inspection and quality control of platelet concentrates obtained by apheresis: The situation in Spain.
Azucena Castrillo, Teresa Jimenez-Marco, José L Arroyo, María L Jurado, Luis Larrea, Jorge Monge

Transfus Apher Sci· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
Anna Gil Sánchez, Eugenia Lacasa Andrade, Joan Valls Marsal, Lourdes Assens Tauste, Cristina González Mingot, Jorge Lecina Monge

Int J Neurosci· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Origin of the right coronary artery from the opposite sinus of Valsalva in adults: characterization by intravascular ultrasonography at baseline and after stent angioplasty.
Paolo Angelini, Carlo Uribe, Jorge Monge, Jonathan M Tobis, MacArthur A Elayda

Catheter Cardiovasc Interv· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.
Klaus M Kortüm, Christian Langer, Jorge Monge, Laura Bruins, Jan B Egan

Br J Haematol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective.
Cristina Eguizabal, Olatz Zenarruzabeitia, Jorge Monge, Silvia Santos, Miguel Angel Vesga

Front Immunol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1.
Laura Amo, Estíbaliz Tamayo-Orbegozo, Natalia Maruri, Cristina Eguizabal, Olatz Zenarruzabeitia, Jorge Monge

Front Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sudden cardiac arrest at the finish line: in coronary ectopia, the cause of ischemia is from intramural course, not ostial location.
Steven Joggerst, Jorge Monge, Carlo Uribe, Scott Sherron, Paolo Angelini

Tex Heart Inst J· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biventricular takotsubo cardiomyopathy: case report and general discussion.
Paolo Angelini, Jorge Monge, Leo Simpson

Tex Heart Inst J· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staging and prognostication of multiple myeloma.
Rafael Fonseca, Jorge Monge, Meletios A Dimopoulos

Expert Rev Hematol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic factors and pathogenesis of Waldenström's macroglobulinemia.
Jorge Monge, Esteban Braggio, Stephen M Ansell

Curr Oncol Rep· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloma: classification and risk assessment.
Rafael Fonseca, Jorge Monge

Semin Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis